Thomas Equels

Thomas K. Equels, M.S., J.D., is the Executive Vice Chairman, Chief Executive Officer, President, and Secretary of Hemispherx Biopharma, Inc., the manufacturer of Ampligen. He was named the CEO in February 2016 after the departure of Dr. William Carter, having previously served as chief financial officer since 2013.

Talks and interviews

 * 2016, Small Cap Nation - ME/CFS (Updated)

Learn more

 * 2016, Hemispherx BioPharma CEO Explains Chronic Fatigue Syndrome And How The Company Is Treating It